ChREBP: a glucose-activated transcription factor involved in the development of metabolic syndrome
about
Role of Transcription Factors in Steatohepatitis and Hypertension after Ethanol: The Epicenter of MetabolismRegulation of glucose metabolism from a liver-centric perspectiveEpigenetic mechanisms underlying the link between non-alcoholic fatty liver diseases and nutritionFunctional interactions among members of the MAX and MLX transcriptional network during oncogenesisCCAAT/enhancer binding protein β in relation to ER stress, inflammation, and metabolic disturbancesPPP2R5C Couples Hepatic Glucose and Lipid HomeostasisA combined transcriptomics and lipidomics analysis of subcutaneous, epididymal and mesenteric adipose tissue reveals marked functional differencesGlucose induces FGF21 mRNA expression through ChREBP activation in rat hepatocytesComparative Genomics of Mycoplasma bovis Strains Reveals That Decreased Virulence with Increasing Passages Might Correlate with Potential Virulence-Related Factors.High glucose-induced O-GlcNAcylated carbohydrate response element-binding protein (ChREBP) mediates mesangial cell lipogenesis and fibrosis: the possible role in the development of diabetic nephropathyNuclear factor erythroid 2-related factor 2 deletion impairs glucose tolerance and exacerbates hyperglycemia in type 1 diabetic mice.Progression of diet induced nonalcoholic steatohepatitis is accompanied by increased expression of Kruppel-like-factor 10 in mice.Topics in transcriptional control of lipid metabolism: from transcription factors to gene-promoter polymorphisms.The effect of whole grain wheat sourdough bread consumption on serum lipids in healthy normoglycemic/normoinsulinemic and hyperglycemic/hyperinsulinemic adults depends on presence of the APOE E3/E3 genotype: a randomized controlled trial.Steatosis and steatohepatitis: complex disorders.Maternal magnesium deficiency in mice leads to maternal metabolic dysfunction and altered lipid metabolism with fetal growth restrictionNovel insights on interactions between folate and lipid metabolism.Genetic determinants of plasma triglyceridesGlucose 6P binds and activates HlyIIR to repress Bacillus cereus haemolysin hlyII gene expression.Fructus Xanthii attenuates hepatic steatosis in rats fed on high-fat diet.Fatty acid synthase modulates homeostatic responses to myocardial stress.Potential epigenetic mechanism in non-alcoholic Fatty liver diseaseGWAS of butyrylcholinesterase activity identifies four novel loci, independent effects within BCHE and secondary associations with metabolic risk factorsSteatoNet: the first integrated human metabolic model with multi-layered regulation to investigate liver-associated pathologies.Differential effects of krill oil and fish oil on the hepatic transcriptome in miceBerberine-loaded solid lipid nanoparticles are concentrated in the liver and ameliorate hepatosteatosis in db/db miceThe contribution of CLIP2 haploinsufficiency to the clinical manifestations of the Williams-Beuren syndrome.Effects of omega-3 carboxylic acids on lipoprotein particles and other cardiovascular risk markers in high-risk statin-treated patients with residual hypertriglyceridemia: a randomized, controlled, double-blind trialAssociations of ChREBP and Global DNA Methylation with Genetic and Environmental Factors in Chinese Healthy AdultsFermented rice bran supplementation mitigates metabolic syndrome in stroke-prone spontaneously hypertensive rats.Activation of the transcription factor carbohydrate-responsive element-binding protein by glucose leads to increased pancreatic beta cell differentiation in ratsFree Triiodothyronine and Cholesterol Levels in Euthyroid Elderly T2DM Patients.Effects of insulin resistance and hepatic lipid accumulation on hepatic mRNA expression levels of apoB, MTP and L-FABP in non-alcoholic fatty liver disease.Combined pharmacological activation of AMPK and PPARδ potentiates the effects of exercise in trained mice.Nuclear transport modulation reduces hypercholesterolemia, atherosclerosis, and fatty liver.Impaired contractile responses and altered expression and phosphorylation of Ca(2+) sensitization proteins in gastric antrum smooth muscles from ob/ob mice.Mechanisms of chronic state of inflammation as mediators that link obese adipose tissue and metabolic syndromeCarbohydrate response element binding protein gene expression is positively regulated by thyroid hormone.Effects of low-carbohydrate diet therapy in overweight subjects with autoimmune thyroiditis: possible synergism with ChREBP.Variation in genes related to hepatic lipid metabolism and changes in waist circumference and body weight.
P2860
Q26746981-ED1ED773-7C95-46EC-BDAC-43139B312831Q26766488-FCCD6958-4441-44A6-90F1-52893EEB7F2FQ26822513-07306D6B-A014-4163-9A9A-BC9A6C8FF22DQ26853567-4D5381CA-26CF-472F-B48A-8C12A39D99C8Q26864146-102763EF-DAD1-4088-BE13-87CDF2469C77Q27310235-416D42D6-E5F3-455C-8DEB-98A4B7C4D230Q27323971-E2D9F92C-20BD-4EFC-AC3F-09498BCE6776Q28571616-7EC4535A-B127-4ECA-93D7-96D6460277ADQ33660689-AE4E957F-66E7-4001-84C1-F95412E24EF9Q33676739-F7F20A15-F7E7-4761-9667-E73A8BA452F8Q33755271-1806AF2F-DBEA-45A6-8386-AE0679821192Q33863032-22040D7E-5179-421C-A9B7-CBDA557D8117Q33879733-5122AF67-C562-487C-B565-471D011A0939Q33881838-BCF12BAE-BA3E-4ECF-8B9A-861A9D0F6BD9Q33907632-0F724321-6FF6-4927-B904-41D860789586Q34129747-B5FD063F-2E46-4C6B-8EC9-F3A69731AEAEQ34130356-91C6303C-9F8C-4D7B-A441-F78E1CBE3E11Q34503333-7629668A-359D-4C3A-9261-051B5B2E7A8EQ34584095-90916066-60C0-4FE4-A538-1FD256EE8680Q34668012-AFDD1853-BB02-49A6-B01D-E2D7B539A114Q35183031-A0488345-126C-4C29-AA3B-580D097034B4Q35380845-D7E5D00C-6627-4373-8FCB-5F8810DFE35FQ35389546-C740A7F5-1C8F-4389-843A-38B79D0B5D2CQ35513572-E558FB21-1DBF-462D-A54B-57C126BA49FFQ35711254-3461A613-02EE-4F15-A8B1-48ECDC34A9C4Q35935053-D32B0F7A-A7B2-40B0-8B5F-78E2A48C941EQ36017050-E47F8E81-968E-47B1-96EF-E10D83736F97Q36019971-C89CAF53-11A7-4926-A70D-458C07F5226CQ36047040-C21A0D91-0A69-41B4-8A6F-72443883803EQ36184925-8A0F865D-B8CF-4FD6-BDD1-193C8F9130D6Q36208159-DE30CF37-E452-40CF-81BC-85D2FE446D63Q36224853-5C4CEF7A-4F21-49D1-9C11-5F4EE1EDF826Q36230931-E6995906-63B5-48EC-822A-78586587CF6AQ36773746-C0A52D66-5287-49DE-B091-4353CBAEDDE7Q36824716-2F573DCC-D60B-4438-8C33-3BF354EEAA66Q36837316-2E53F233-988D-4D9B-A108-695A9C4510E1Q36970120-DB666DD8-5FB3-42AE-ADC2-75AEE6B0D499Q37244695-65742328-22B8-4E08-8C63-B68E3011C7D5Q37265667-CF04D5AC-C646-4D23-8F74-26CD8B66D856Q37669828-01D0DDD0-38ED-48D3-B8B4-581578178DF4
P2860
ChREBP: a glucose-activated transcription factor involved in the development of metabolic syndrome
description
2008 nî lūn-bûn
@nan
2008 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2008 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
name
ChREBP: a glucose-activated tr ...... elopment of metabolic syndrome
@ast
ChREBP: a glucose-activated tr ...... elopment of metabolic syndrome
@en
ChREBP: a glucose-activated tr ...... elopment of metabolic syndrome
@nl
type
label
ChREBP: a glucose-activated tr ...... elopment of metabolic syndrome
@ast
ChREBP: a glucose-activated tr ...... elopment of metabolic syndrome
@en
ChREBP: a glucose-activated tr ...... elopment of metabolic syndrome
@nl
prefLabel
ChREBP: a glucose-activated tr ...... elopment of metabolic syndrome
@ast
ChREBP: a glucose-activated tr ...... elopment of metabolic syndrome
@en
ChREBP: a glucose-activated tr ...... elopment of metabolic syndrome
@nl
P3181
P356
P1433
P1476
ChREBP: a glucose-activated tr ...... elopment of metabolic syndrome
@en
P2093
Yukio Horikawa
P304
P3181
P356
10.1507/ENDOCRJ.K07E-110
P407
P577
2008-05-19T00:00:00Z